Physician profile
Shiva Adham
NPI 1003488214
$2,039.99
in general payments reported to CMS, 2019-2025
18 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $152 · 2023: $327 · 2024: $1,178 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,866 · Education: $21.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.13 |
| Education | $21.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $326.10 | 2023-2025 | Tarpeyo |
| Astrazeneca Pharmaceuticals LP | $233.68 | 2022-2024 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.51 | 2023-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $195.88 | 2024-2025 | |
| Travere Therapeutics, INC. | $195.79 | 2023-2025 | |
| Amgen INC. | $176.30 | 2022-2025 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $165.91 | 2023-2025 | Jynarque, Voyxact |
| Ardelyx, INC. | $123.19 | 2023-2025 | Ibsrela |
| Ani Pharmaceuticals, INC. | $114.06 | 2024 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $70.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.76 | 2024 | |
| Fresenius USA Marketing, INC. | $45.26 | 2024 | Velphoro |
| Scpharmaceuticals INC. | $35.20 | 2024 | |
| Recordati_rare_diseases_inc. | $26.09 | 2023 | Isturisa, Signifor Lar |
| Daiichi Sankyo INC. | $23.32 | 2024 | Injectafer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $21.67 | 2023 | Rayaldee |
| Mallinckrodt Hospital Products INC. | $17.42 | 2023 | Acthar |
| Glaxosmithkline, LLC. | $15.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiva Adham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.